Apollo taps W2O as LAP-BAND AOR

Share this article:

Apollo EndoSurgery has tapped W2O Group as its agency of record for its LAP-BAND weight reduction system. The agency will look to lift the procedure's profile through advertising, digital engagement and multi-channel marketing efforts. "W2O came to the table with a deep understanding of what we are looking to achieve as a brand and how it fits into our portfolio of gastroenterological products,” president and CEO of Apollo Endosurgery Dennis McWilliams stated in a release.

Jim Weiss, CEO of W2O, offered, “We could not be more enthusiastic to partner with Apollo to write the next exciting chapter of the brand story.”

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.